Robert A. Beardsley
No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Oct 1: return to the company (17,948 ABUS shares).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade Robert A. Beardsley reported
None in the last 12 months, as filed.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Robert A. Beardsley's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 0 |
Alerts for Robert A. Beardsley
Use this page
How to cite
Breakaway, Robert A. Beardsley: Director at Arbutus Biopharma (ABUS), Oct 1, 2026, getbreakaway.com/insiders/robert-a-beardsley
Journalists: email support@getbreakaway.com for the data behind this page.